Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Greenwich LifeSciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 27 | 31 | +4 |
| Shares | 536.0K | 644.8K | +108.9K (+20.3%) |
| Value | $5.64M | $12.9M | +$7.22M (+128.0%) |
New holders (7)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 41,505 | $827.6K | 0.00% |
| Susquehanna International Group, LLP | 35,870 | $715.2K | 0.00% |
| HRT Financial LP | 15,165 | $302.0K | 0.00% |
| Man Group plc | 11,365 | $226.6K | 0.00% |
| Old Point Trust & Financial Services N A | 100 | $1.99K | 0.00% |
| Macquarie Group Ltd | 110 | $2 | 0.00% |
| Capital Advisors, Ltd. LLC | 3 | $0 | 0.00% |
Sold out (3)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Ameriprise Financial Inc | 53,647 | $564.4K |
| 683 Capital Management, LLC | 19,604 | $206.2K |
| AdvisorNet Financial, Inc | 50 | $526 |